Urocanic acid derivatives useful for the treatment of immune-related and inflammatory diseases

Details for Australian Patent Application No. 2008262664 (hide)

Owner Valletta Health IP EE B.V.

Inventors Kammeijer, Arthur

Agent Freehills

Pub. Number AU-A-2008262664

PCT Pub. Number WO2008/153385

Priority 0711234.5 11.06.07 GB; 0718543.2 21.09.07 GB; 60/944,382 15.06.07 US

Filing date 11 June 2008

Wipo publication date 18 December 2008

International Classifications

C07D 233/64 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/4166 (2006.01)

A61K 31/4172 (2006.01)

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 39/06 (2006.01) General protective or antinoxious agents

C07D 233/70 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Event Publications

14 January 2010 PCT application entered the National Phase

  PCT publication WO2008/153385 Priority application(s): WO2008/153385

15 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008262670-Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide

2008262654-Dust sealing